D. D. Des Jarlais

Statistics and Probability · 2004–2018

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom D. D. Des Jarlais trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. David Moher

Who trusts D. D. Des Jarlais overall

  1. A. McQueen
  2. Susan Michie
  3. Russell E. Glasgow
  4. William M. P. Klein
  5. C. Hollin
  6. L. Green
  7. D. Fixsen
  8. Stefanie L Williams

Papers from D. D. Des Jarlais's perspective

Ordered by how strongly the researchers D. D. Des Jarlais trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Evidence-based public health: moving beyond randomized trials. (American Journal of Public Health)
  2. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. (Journal of the American Medical Association (JAMA))
  3. A comparison of observational studies and randomized, controlled trials. (New England Journal of Medicine)
  4. Principles of multilevel modelling. (International Journal of Epidemiology)
  5. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term… (Journal of the American Medical Association (JAMA))
  6. What is missing from descriptions of treatment in trials and reviews? (British medical journal)
  7. Systematic reviews in health care: Assessing the quality of controlled clinical trials. (British medical journal)
  8. Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
  9. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
  10. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (New England Journal of Medicine)

Their papers